Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.53 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12987888 | 0.95 | CYP1A2 (0.51) | CYP1A2CYP2C9CYP4Z1POLBMAPT | |
| SCHEMBL68851 | 0.90 | CYP4Z1 (0.62) | CYP4Z1POLBMAPTKMT2AMEN1 | |
| SCHEMBL4812296 | 0.86 | KMT2A (0.48) | CYP1A2CYP2C9CYP4Z1POLBMAPT | |
| SCHEMBL1124344 | 0.85 | CYP4Z1 (0.54) | CYP4Z1POLBMAPTKMT2AMEN1 | |
| SCHEMBL68930 | 0.84 | CYP4Z1 (0.57) | CYP4Z1MAPTLMNAMAPK1ALDH1A1 | |
| SCHEMBL1107146 | 0.84 | CYP4Z1 (0.57) | CYP1A2CYP2C9CYP4Z1MAPTKMT2A | |
| SCHEMBL10299459 | 0.84 | CYP4Z1 (0.57) | CYP4Z1POLBMAPTKMT2AMEN1 | |
| SCHEMBL6057577 | 0.84 | CYP4F2 (0.59) | CYP4Z1POLBMAPTKMT2AMEN1 | |
| SCHEMBL6207253 | 0.82 | CYP4Z1 (0.55) | CYP4Z1POLBMAPTKMT2AMEN1 | |
| SCHEMBL5545889 | 0.82 | CYP4Z1 (0.55) | CYP4Z1POLBMAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119080664-A | Preparation method of Fu Kasai ethyl acetate | 南京康立瑞生物科技有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118184581-A | Synthesis and application of Delta opioid receptor biased agonist compound and analgesic drug | 中国科学院大连化学物理研究所 | 2024-06-14 | — | — | CN | claimed |
| CN-111511725-B | 1-cyano-2- (4-cyclopropyl-benzyl) -4-) (beta-D-glucopyranos-1-yl) -benzene Synthesis of 1:1:1 Co-crystals of L-proline and Water | 勃林格殷格翰维特梅迪卡有限公司 | 2024-04-09 | — | — | CN | claimed |
| EP-4309002-A1 | RECORDING A LATENT HOLOGRAPHIC GRATING AND AMPLIFICATION OF ITS DYNAMIC RANGE | META PLATFORMS TECHNOLOGIES, LLC (US) | 2024-01-24 | — | — | EP | claimed |
| CN-117321088-A | Preparation of monodisperse Polymer beads by Room temperature initiation | 深圳华大基因科技有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117305864-A | alpha-Fe 2 O 3 Porphyrin-based MOFs core-shell photoelectric catalyst and preparation method and application thereof | 石家庄铁道大学 | 2023-12-29 | — | — | CN | claimed |
| CN-108997526-B | Synthesis method of azide group-containing copolymer | 江南大学 | 2020-11-06 | — | — | CN | claimed |
| CN-111511725-A | Synthesis of 1:1:1 cocrystals of 1-cyano-2- (4-cyclopropyl-benzyl) -4- (β -D-glucopyranos-1-yl) -benzene, L-proline and water | 勃林格殷格翰维特梅迪卡有限公司 | 2020-08-07 | — | — | CN | claimed |
| CN-122010924-A | Aminothiazole heterocyclic compound containing pyridone and synthesis and application thereof | 浙江大学 | 2026-05-12 | — | — | CN | disclosed |
| EP-4727537-A2 | SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF | Adaxion Therapeutics, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260092053-A1 | KHK INHIBITORS | GILEAD SCIENCES INC (US) | 2026-04-02 | — | — | US | disclosed |
| CN-121735764-A | Preparation method of ethyl 4-bromophenylacetate | 上海北卡医药技术有限公司 | 2026-03-27 | — | — | CN | disclosed |
| CN-121735764-A | Preparation method of ethyl 4-bromophenylacetate | 上海北卡医药技术有限公司 | 2026-03-27 | — | — | CN | disclosed |
| EP-4695250-A1 | TETRACYCLIC COMPOUNDS AS SMARCA2 AND/OR SMARCA4 DEGRADERS | Aurigene Oncology Limited (IN) | 2026-02-18 | — | — | EP | disclosed |
| US-4820715-A | TREATING NAUSEA AND GASTRIC DISORDERS | BRISTOL-MYERS COMPANY (US) | 1989-04-11 | — | — | US | disclosed |
| US-4808624-A | ANTIEMETICS | BRISTOL-MYERS COMPANY (US) | 1989-02-28 | — | — | US | disclosed |
| US-4417052-A | ANTIINFLAMMATORY AGENTS; ANALGESICS; VIRICIDES | STERLING DRUG INC. (US) | 1983-11-22 | — | — | US | disclosed |
| US-4308382-A | ANTIINFLAMMATORY AGENTS | STERLING DRUG INC. (US) | 1981-12-29 | — | — | US | disclosed |
| US-4279918-A | ANTIDEPRESSANTS, STIMULANTS | BYK GULDEN LOMBERG CHEMISCHE FABRIK G.M.B.H. (DE) | 1981-07-21 | — | — | US | disclosed |
| US-4153724-A | Benzoyl phenoxy acetic acid derivatives | KAKEN CHEMICAL CO., LTD. (JP) | 1979-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092053-A1 | KHK INHIBITORS | KHK, SLC5A2, HK1 | CYP1A2 774/4885CYP2C9 377/4885CYP4Z1 2076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.